Paper Details

  1. Home
  2. Paper Details

Modes of action of diclofenac 3%/hyaluronic acid 2.5% in the treatment of actinic keratosis.

Author: Lange-AsschenfeldtSusanne, MaltuschAdrienne, MatthiesCarmen, Röwert-HuberJoachim, StockflethEggert

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study evaluates the potential molecular and cellular main modes of action of topically applied diclofenac in the treatment of actinic keratoses (AKs).
Paper Details　
Original Abstract of the Article :
The efficacy of topically applied diclofenac 3 % in combination with hyaluronic acid 2.5 % in the treatment of actinic keratoses (AKs) has been demonstrated in several clinical studies, but the exact mode of action is still unclear. This study evaluates the potential molecular and cellular main mode...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1610-0387.2011.07700.x

データ提供：米国国立医学図書館（NLM）

Diclofenac 3%/Hyaluronic Acid 2.5%: A New Weapon in the Desert of Actinic Keratosis

Actinic keratosis (AK) is a common skin condition that can develop into skin cancer. This research explores the potential mechanisms of action of diclofenac 3% in combination with hyaluronic acid 2.5% in the treatment of AK. It's like delving into the intricate workings of a desert oasis, discovering how specific elements interact to create a thriving environment.

The researchers investigated the molecular and cellular mechanisms by which diclofenac affects AK. They explored how this medication interacts with skin cells and the pathways involved in the development and treatment of AK. This research is like studying the intricate web of relationships within a desert ecosystem, uncovering the secrets of its resilience and adaptability.

A Multifaceted Approach to Skin Health

The researchers found that diclofenac 3% in combination with hyaluronic acid 2.5% may have multiple modes of action, targeting different cellular processes involved in AK. It's like finding a multi-faceted oasis in the desert, offering a diverse range of resources to promote growth and well-being.

A Deeper Understanding of Skin Health

This research contributes to a deeper understanding of the mechanisms involved in AK treatment. It's like discovering a new layer of the desert's hidden depths, revealing the intricate workings of a complex ecosystem. Further research is needed to fully elucidate the mechanisms of action of this combination therapy and to optimize its effectiveness.

Dr.Camel's Conclusion

This research provides valuable insights into the mechanisms of action of diclofenac 3% in combination with hyaluronic acid 2.5% in the treatment of actinic keratosis. It's like peering into the heart of a desert oasis, uncovering the complex web of interactions that sustain its vibrant life. This research highlights the potential of this combination therapy as a promising treatment option for AK, offering a new path towards healthier skin and a brighter future for those affected by this condition.

Date :
  1. Date Completed 2012-04-17
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

21585654

DOI: Digital Object Identifier

10.1111/j.1610-0387.2011.07700.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.